Search Orphan Drug Designations and Approvals
-
Generic Name: | Beraprost |
---|---|
Date Designated: | 04/29/1999 |
Orphan Designation: | Treatment of pulmonary arterial hypertension associated with any New York Heart Association classification (Class I, II, III, or IV). |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 04/02/2020 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
LungRx, Inc. 1040 Spring Street Silver Spring, Maryland 20910 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-